A major new international study has found that combining specific biological markers with sociodemographic factors dramatically improves the ability to predict which adolescents will go on to develop depression. Nearly half of adolescents rated high‑risk on both biological and sociodemographic factors developed depression within three years. None of the adolescents rated low‑risk on both measures developed depression. This may pave the way for the first clinically feasible early‑warning system for one of the world’s most common and disabling mental health conditions.
By
NIHR Maudsley BRC at 2 Mar 2026
A new UK-wide clinical trial led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has evaluated a self-guided behavioural sleep programme for the parents of children with epilepsy.
By
NIHR Maudsley BRC at 7 Jan 2026
In 2025, NIHR Maudsley BRC delivered research with real-world impact from evaluating new treatments for depression and migraine to developing innovative approaches to monitoring opioid overdose and diagnosing eating disorders.
By
NIHR Maudsley BRC at 19 Dec 2025
Antidepressants differ widely in how they affect the body, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in collaboration with the University of Oxford.
By
NIHR Maudsley BRC at 22 Oct 2025
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and the social enterprise Breathe Arts Health Research has shown that a specially designed group singing intervention, Breathe Melodies for Mums, is an effective and acceptable way to treat mothers with postnatal depression.
By
NIHR Maudsley BRC at 15 Oct 2025
